Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
JAZF1 antisense RNA 1 (JAZF1-AS1)
- Target
- JAZF1-AS1
- Molecular classification
- Other (Antisense chimeric RNA)
01
Overview
JAZF1 antisense RNA 1 (JAZF1-AS1) is not a well-characterized endogenous RNA molecule. It refers to artificially designed antisense chimeric RNAs targeting sequences within the JAZF1 gene locus. Such antisense RNAs, when expressed in cells, have been shown in laboratory models to induce gene fusions—specifically, experimental studies have used antisense chimeric RNAs to induce the fusion transcript JAZF1-SUZ12, which is implicated in endometrial stromal sarcoma. However, there is not yet evidence of a naturally occurring, endogenous JAZF1-AS1 transcript serving as a therapeutic target or having a defined biological role. Canonically, antisense RNAs are regulatory non-coding RNAs that can modulate gene expression, but in the context of JAZF1, the designated "JAZF1-AS1" appears only in artificial constructs and not as a validated molecular entity[1][2].
02
Mechanism of action
None known. The molecule does not correspond to a drug target.
03
Biological functions
Possibly initiates gene fusion (experimental context only)
04
Disease associations
Possible role in the initiation of fusion genes such as JAZF1-SUZ12 in endometrial stromal sarcoma—studied only in artificial/exogenous settings
05
Safety considerations
None documented; antisense chimeric RNAs may have theoretical risks associated with genome modification, but this is not a clinically characterized risk for JAZF1-AS1
Beyond the preview
Go deeper on JAZF1 antisense RNA 1 (JAZF1-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on JAZF1 antisense RNA 1 (JAZF1-AS1).